MedTech Dive September 25, 2024
Susan Kelly

Michelle Brennan was named acting CEO of the patient monitoring company following Joe Kiani’s defeat in a proxy battle with an activist investor.

Dive Brief:

  • Masimo CEO and founder Joe Kiani resigned from the company after losing his board seat last week in a proxy battle with Politan Capital Management.
  • Former Johnson & Johnson executive Michelle Brennan, who was elected to Masimo’s board last year with Politan’s support, was named interim CEO effective immediately, according to a Wednesday announcement.
  • Masimo reaffirmed its financial guidance for the third quarter on a non-GAAP basis. CFO Micah Young and Chief Operating Officer Bilal Muhsin said they would provide more details on an earnings call in October.

Dive Insight:

Kiani’s resignation 35...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

Continue Reading

 
Topics: Medical Devices
Related Articles:
Phillips launches updated AI tech for MRI scanners
Biocompatible Nanoparticles: Tiny Antennae with Huge Potential for Brain-Computer Interfaces
Building Solid Relationships with Universities Critical for Early Stage Medtech Investors
Teleflex to split in 2, buy Biotronik assets for $791M among slew of actions
Thermo Fisher Beefs Up in Bioprocessing With $4B Acquisition of Solventum Biz Segment

Share This Article